Professional
Added to YB: 2024-09-10
Pitch date: 2024-06-30
DXCM [bullish]
DexCom, Inc.
-40.74%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$113.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Carillon Eagle Mid Cap Growth Fund Porfolio Holding - DexCom, Inc.
DXCM: Pioneer in CGM systems for diabetics. Large untapped market vs finger prick tests. Stock down despite beating estimates & raising guidance. New products & insulin pump integration offer growth. Huge opportunity in Type 1 & growing Type 2 diabetic markets.
Read full article (1 min)